Jane Street Group, LLC Vir Biotechnology, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 130,347 shares of VIR stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,347
Previous 192,451 32.27%
Holding current value
$1.39 Million
Previous $1.71 Million 42.99%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.26 - $10.7 $450,875 - $664,512
-62,104 Reduced 32.27%
130,347 $976,000
Q2 2024

Aug 14, 2024
BUY
$7.63 - $12.66 $701,509 - $1.16 Million
91,941 Added 91.47%
192,451 $1.71 Million
Q1 2024

May 15, 2024
BUY
$8.6 - $11.9 $233,954 - $323,727
27,204 Added 37.11%
100,510 $1.02 Million
Q4 2023

Feb 14, 2024
BUY
$7.76 - $10.29 $347,997 - $461,455
44,845 Added 157.57%
73,306 $737,000
Q3 2023

Nov 14, 2023
SELL
$9.14 - $24.62 $1.02 Million - $2.76 Million
-111,924 Reduced 79.73%
28,461 $266,000
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $2.35 Million - $2.77 Million
101,410 Added 260.19%
140,385 $3.44 Million
Q1 2023

May 15, 2023
BUY
$22.26 - $30.85 $631,226 - $874,813
28,357 Added 267.07%
38,975 $906,000
Q4 2022

Feb 14, 2023
SELL
$19.96 - $28.22 $1.24 Million - $1.75 Million
-61,994 Reduced 85.38%
10,618 $268,000
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $1.18 Million - $2.01 Million
64,509 Added 796.11%
72,612 $1.4 Million
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $1.18 Million - $2.01 Million
64,509 Added 796.11%
72,612 $1.4 Million
Q2 2022

Aug 16, 2022
SELL
$19.08 - $26.7 $2.34 Million - $3.27 Million
-122,518 Reduced 93.8%
8,103 $206,000
Q1 2022

May 17, 2022
BUY
$21.19 - $40.01 $77,618 - $146,556
3,663 Added 2.89%
130,621 $3.36 Million
Q4 2021

Feb 15, 2022
BUY
$30.97 - $54.03 $2.83 Million - $4.93 Million
91,287 Added 255.91%
126,958 $5.32 Million
Q3 2021

Nov 16, 2021
BUY
$34.9 - $54.54 $555,817 - $868,604
15,926 Added 80.66%
35,671 $1.55 Million
Q2 2021

Aug 16, 2021
SELL
$38.75 - $51.0 $264,817 - $348,534
-6,834 Reduced 25.71%
19,745 $933,000
Q4 2020

Feb 17, 2021
SELL
$25.51 - $43.38 $100,636 - $171,134
-3,945 Reduced 12.92%
26,579 $712,000
Q3 2020

Nov 17, 2020
SELL
$28.28 - $53.6 $709,884 - $1.35 Million
-25,102 Reduced 45.13%
30,524 $1.05 Million
Q2 2020

Aug 17, 2020
BUY
$27.89 - $47.86 $1.55 Million - $2.66 Million
55,626 New
55,626 $2.28 Million

Others Institutions Holding VIR

# of Institutions
215
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.41B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email